Riding high on Wegovy, Novo Nordisk doubled its workforce. Now layoffs loom
As Novo Nordisk‘s sales of its blockbuster weight-loss drug Wegovy boomed, the Danish drugmaker raced to expand manufacturing capacity and sales outreach with a hiring spree that almost doubled staff numbers over five years. Now sales are slowing and layoffs loom. Annual reports show that Novo’s workforce grew from around 43,260 employees in 2019 to … Read more